vimarsana.com

Latest Breaking News On - Novelos therapeutics inc - Page 1 : vimarsana.com

Cellectar Biosciences (NASDAQ:CLRB) Downgraded to Hold at Zacks Investment Research

Cellectar Biosciences (NASDAQ:CLRB – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Tuesday, Zacks.com reports. According to Zacks, “Cellectar Biosciences, Inc. is developing agents to detect, treat and monitor a broad spectrum of cancers. It uses a […]

Research Analysts Weekly Ratings Changes for Cellectar Biosciences (CLRB)

Several analysts have recently updated their ratings and price targets for Cellectar Biosciences (NASDAQ: CLRB): 5/29/2022 – Cellectar Biosciences is now covered by analysts at StockNews.com. They set a “sell” rating on the stock. 5/26/2022 – Cellectar Biosciences had its price target lowered by analysts at Maxim Group to $1.25. 5/24/2022 – Cellectar Biosciences was […]

Equities Research Analysts Updated EPS Estimates for May 24th (CENTA, CGC, CHCT, CLGN, CLRB, CMPO, CORZ, CRDL, CRH, CRHKY)

Equities Research Analysts’ updated eps estimates for Tuesday, May 24th: Central Garden & Pet (NASDAQ:CENTA) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $45.00 price target on the stock. According to Zacks, “Central Garden & Pet Company is a leading innovator, marketer […]

Cellectar Biosciences (NASDAQ:CLRB) Lifted to Buy at Zacks Investment Research

Cellectar Biosciences (NASDAQ:CLRB – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a note issued to investors on Tuesday, Zacks.com reports. The firm currently has a $0.50 target price on the biopharmaceutical company’s stock. Zacks Investment Research‘s price objective points to a potential upside of 42.05% […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.